Genetic Variant Linked to Rare Kidney Syndrome

Researchers identified a specific mutation in an adolescent with a complex condition mimicking Bartter syndrome.

Updated on Sept. 29, 2026 in Asthma

Microscopic view of human renal tissue featuring intricate cellular patterns and fibrous networks under cool clinical light.
Researchers have identified a homozygous splice-altering EGFR gene variant as the cause of a rare kidney syndrome in an adolescent patient. AI Illustration. Upload story photo >

Scientists have identified a homozygous splice-altering EGFR variant in an adolescent patient who presented with symptoms resembling Bartter-like syndrome. The findings provide new insight into the complex clinical presentation of this genetic condition.

Why it matters

Identifying specific genetic drivers helps clarify the mechanisms behind rare, multi-system disorders that manifest with both kidney and skin-related symptoms. This discovery expands our understanding of how EGFR gene mutations can impact systemic health beyond standard diagnostic expectations.

Using exome sequencing and homozygosity mapping on chromosome 7p, researchers identified the c.2702-2A>G variant. RNA-Seq and RT-PCR confirmed this mutation causes the retention of 27 nucleotides from intron 22, resulting in reduced EGFR protein levels.

The players

EGFR

The epidermal growth factor receptor gene, which encodes a protein crucial for cell growth and division.

The details

The identified mutation disrupts the normal splicing process of the EGFR gene, leading to the incorrect retention of genetic material in the resulting mRNA. This molecular error produces a deficient version of the EGFR protein, which was confirmed via immunofluorescence analysis of the patient's skin. The resulting systemic deficiency contributes to the patient's complex presentation of nephrocalcinosis, hypercalciuria, and autoinflammatory skin symptoms.

Timeline

  1. 2026-09-29

    The research findings were published.

Health Landscape

This discovery marks a significant expansion of the clinical scope associated with the EGFR signaling pathway. It adds to the growing body of research mapping how isolated mutations can produce diverse, multi-systemic effects in patients.

While this finding is specific to an individual case, it underscores the value of genetic testing for patients with unexplained, multi-organ symptoms. If you or a family member face persistent, complex symptoms, discuss the potential for genetic evaluation with your physician.

The takeaway

This case highlights the importance of precise genetic mapping in unraveling rare, overlapping clinical syndromes. Families navigating complex or multi-symptom diagnoses should work with a medical geneticist to explore the current state of diagnostic testing.

Further reading

For broader insights into the diagnostic challenges of chronic genetic conditions, explore our Asthma resources.

Source note: This article includes information reported by Journal of Medical Genetics.